Employees Retirement System of Texas’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-42,000
Closed -$1.61M 378
2022
Q2
$1.61M Hold
42,000
0.02% 561
2022
Q1
$1.74M Hold
42,000
0.02% 583
2021
Q4
$1.59M Hold
42,000
0.02% 581
2021
Q3
$1.38M Buy
42,000
+24,000
+133% +$935K 0.02% 620
2021
Q2
$1.21M Hold
18,000
0.01% 642
2021
Q1
$1.02M Hold
18,000
0.01% 666
2020
Q4
$1.47M Hold
18,000
0.02% 543
2020
Q3
$1.28M Buy
+18,000
New +$1.4M 0.02% 598

Other funds holding AXSM

Employees Retirement System of Texas's AXSM Position: Q3 2022 in Review

Employees Retirement System of Texas sold out of Axsome Therapeutics (AXSM) in Q3 2022, closing a stake of 42,000 shares — an estimated $1.61M sold.

Employees Retirement System of Texas first reported a position in AXSM in Q3 2020 and held it in 8 quarters. The position peaked at $1.74M in Q1 2022. 189 funds tracked by Wall St. Rank hold AXSM as of Q3 2022.

  • Employees Retirement System of Texas reported no remaining Axsome Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Employees Retirement System of Texas sold 42,000 Axsome Therapeutics shares in Q3 2022, an estimated $1.61M.
  • Employees Retirement System of Texas first reported a position in Axsome Therapeutics in Q3 2020 and held it in 8 quarters.
  • Employees Retirement System of Texas's Axsome Therapeutics position peaked at $1.74M in Q1 2022.
  • 189 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2022.

Based on Employees Retirement System of Texas's 13F filing for Q3 2022, filed 10 Nov 2022.